probucol has been researched along with Glomerulonephritis, Membranous in 2 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A significant reduction in proteinuria was seen during the probucol treatment (median (range): 6." | 3.71 | Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study. ( Breiteneder-Geleff, S; Haas, M; Holzer, H; Hörl, WH; Kerjaschki, D; Kramar, R; Mayer, G; Neuweiler, J; Neyer, U; Ratschek, M; Regele, HM; Schneider, B; Wirnsberger, G, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haas, M | 2 |
| Kerjaschki, D | 2 |
| Mayer, G | 2 |
| Wirnsberger, G | 1 |
| Holzer, H | 1 |
| Ratschek, M | 1 |
| Neyer, U | 1 |
| Neuweiler, J | 1 |
| Kramar, R | 1 |
| Schneider, B | 1 |
| Breiteneder-Geleff, S | 1 |
| Regele, HM | 1 |
| Hörl, WH | 1 |
1 review available for probucol and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Lipid-lowering therapy in membranous nephropathy.
Topics: Glomerulonephritis, Membranous; Humans; Hypolipidemic Agents; Lipid Peroxidation; Probucol | 1999 |
1 other study available for probucol and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
Topics: Adult; Anticholesteremic Agents; Antioxidants; Dose-Response Relationship, Drug; Drug Administration | 2002 |